A new Alzheimer's drug brings hope, controversy

The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the approval process for Aduhelm has stirred controversy. Correspondent Susan Spencer talks with experts about the clinical benefits of this new class of drugs; and with early-onset Alzheimer's patients, including a former neurologist who enrolled in an early trial of Aduhelm.

"CBS Sunday Morning" features stories on the arts, music, nature, entertainment, sports, history, science and Americana, and highlights unique human accomplishments and achievements. Check local listings for CBS Sunday Morning broadcast times.

[adriennem]

56k??? The average person could never afford that. Sickening...

[LaRuta-skrr]

Such a devastating and cruel disease. I hope they find a cure soon.

[pamelamays]

56K?
Hopefully, that price will come down.

[MoMo-mobg]

I hope things change soon. Good luck Joe, I will pray for your chance to become a reality.

[josephbellantuono]

My father is suffering from this disease! It would be nice if a cure was found 🙏🤞

[maineyor]

Where are your Closed Captions??? Older people watch your channel and NEED them,

[kathleenbergeron]

Excellent piece by Susan Spencer. Greatest quote: “If you don’t take chances, nothing good happens.” Wow.

[janmuldoon]

Very conflicting information about this Anyway, at $56, 000 dollars a year very few people can afford it anyway.

[jeffha]

My mom died of Alzheimer's in July. Hopefully they find a cure for this horrible disease.

[dangremaus]

I can’t wait to watch this video in 10-15 years again and say “Wow. Remember when we didn’t have a cure for this?”

[TanningMiami]

prayers to all that are suffering . No one is looking into the cause with functional medicine is disheartening

[elisinger]

The sad, sad part is that yet again, the scientists who actually designed and developed the drug were not given any spotlight. Just interviewing physicians who just give out those drugs to their patients. Oh to be a scientist- do all the hard work but not get any recognition or compensation.

[michaelvaladez]

56000. Wow, there is something wrong in our medical, pharmaceutical, government outlook at our health system. We can only hope things will

[jamesdooling]

I watched my Mimi die from AD. I cared for her -- along with her three daughters -- at home for about five years. It is the most devastating of heartbreaking diseases. To watch someone slip away each day... further and further. I hope these drugs continue to be studied and released. There is little you can do to assuage fear, hopelessness, depression and anxiety in AD patients other than drug them into unconsciousness. That only makes the whole ordeal even worse. Cherish those few moments of clarity you get.

[BrianJuntunen]

Life is cruel. It gives so much promise, then it yanks it away. But we fight on. I hope this guy is helped tremendously through medicine and prayer.

[mililaniman]

I have been trying to increase my physical exercise to prevent this. I try to get a good night sleep too.

[CasperCarver]

"I also know what I need to do to hold off the bad stuff". Hey Susan Spencer WHERE"S the follow up question to this

[Maggie-trkd]

$56, 000 per year is too much to pay for a drug not proven to provide any actual clinical benefit to patients; unusual and fast-tracked approval process of aduhelm is presently being investigated by the office of the inspector general

[PageMarker]

Cassava Sciences' Simufilam has shown favorable results in their Phase 2B study group, with Phase 3 recruitment underway.

[vif]

8:05 "they are rare"

expecting Alzheimer patients to tell you how often they have negative side effects sounds pretty reckless, but alright